Definium Therapeutics
The Director, Medical Information leads the medical information strategy and operations at Definium Therapeutics, ensuring accurate and timely scientific responses to healthcare professionals, patients, and caregivers. This role involves overseeing external contact center partners, managing vendor relationships, and driving continuous improvement in inquiry workflows and content systems. The position requires strong scientific expertise, operational leadership, and collaboration across multiple functions to support the company's mission in advancing psychiatric therapeutics.
Headquarters
New York, New York, United States
Company Size
1-10 employees
Founded
2019
Definium Therapeutics (formerly MindMed) is a clinical-stage biopharmaceutical company harnessing the therapeutic potential of psychedelic medicine to develop treatments for psychiatric conditions including generalized anxiety disorder, major depressive disorder, and autism spectrum disorder. Its lead programs include DT120 ODT, a proprietary formulation of lysergide (LSD) D-tartrate, and DT402, the R-enantiomer of MDMA targeting core symptoms of autism spectrum disorder. The company is guided by precision science and evidence-based development to redefine mental healthcare.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Definium Therapeutics.
Director, Medical Information
Dyne Therapeutics
Senior Director, Medical Information
Immatics
Associate Director / Director, Medical Information
Cognito Therapeutics
Scientific Director, Medical Information & Medical Communications
Tango Therapeutics
Director, Medical Information
Revolution Medicines
Medical Information Manager
Sequel Med Tech